Granulomatous disease refers to any condition in which the immune system forms granulomas, small clusters of immune cells that wall off substances the body perceives as threats but cannot eliminate. These clusters most often appear in the lungs, skin, lymph nodes, and liver. The term covers a wide range of conditions, from infections like tuberculosis to immune disorders like sarcoidosis to the rare genetic condition called Chronic Granulomatous Disease (CGD), which affects roughly 1 in 100,000 to 1 in 217,000 births worldwide.
How Granulomas Form
Granulomas are essentially the immune system’s containment strategy. When immune cells called macrophages encounter something they can’t destroy, whether a persistent bacterium, a fungal spore, or a foreign particle, they call in reinforcements. More macrophages arrive, along with other white blood cells. Together, these cells cluster tightly around the threat, forming a small nodule of tissue visible under a microscope.
The process starts when macrophages release signaling molecules that attract additional immune cells to the site. T cells arrive and amplify the response by releasing their own signals, which activate even more macrophages. Over days to weeks, the macrophages at the center of this cluster transform into specialized cells called epithelioid cells, and some fuse together into giant cells. The result is a structured ball of immune cells that effectively quarantines whatever triggered the response. In tuberculosis, for example, T cells take 12 to 21 days after infection to become fully activated and join this process.
This containment works well in many cases, but it comes at a cost. Granulomas can damage the surrounding tissue, disrupt organ function, and persist for months or years if the triggering substance isn’t cleared.
Infectious vs. Non-Infectious Causes
Granulomatous diseases fall into two broad categories based on what triggers the granuloma.
Infectious causes include tuberculosis (the most common worldwide), fungal infections like histoplasmosis, infections caused by atypical mycobacteria, and parasitic infections such as cysticercosis. In these cases, the granuloma forms because the immune system is trying to contain a living organism it cannot fully kill.
Non-infectious causes include sarcoidosis (the most common non-infectious granulomatous disease), vasculitis, foreign body reactions, and Crohn’s disease. In sarcoidosis, for instance, granulomas form in the lungs and other organs without any identifiable infection. The immune system appears to overreact to an unknown trigger.
Pathologists use the microscopic appearance of granulomas to help narrow the diagnosis. Necrotizing granulomas have a core of dead tissue surrounded by a ring of immune cells and are strongly associated with infections like tuberculosis. Non-necrotizing granulomas lack that dead center and consist mainly of epithelioid cells and giant cells with minimal surrounding inflammation. Sarcoidosis is the classic example of this type.
Chronic Granulomatous Disease (CGD)
Chronic Granulomatous Disease is a specific, inherited immune deficiency that deserves its own explanation because it’s often what people encounter when searching this term. CGD is not a disease caused by granulomas in the usual sense. Instead, it’s a genetic condition where certain immune cells can’t produce the chemical burst they need to kill bacteria and fungi after engulfing them.
Normally, when a macrophage or neutrophil swallows a pathogen, it generates a rapid flood of reactive oxygen molecules inside a tiny internal compartment, essentially blasting the pathogen with toxic chemicals. This “oxidative burst” is powered by an enzyme complex called NADPH oxidase. In CGD, mutations in any of six genes that build or assemble this enzyme complex leave the immune cells unable to produce that burst. The pathogens survive inside the very cells meant to destroy them, and the immune system compensates by forming granulomas around the sites of persistent infection.
About 66% of CGD cases are caused by mutations on the X chromosome, which is why the condition disproportionately affects boys. The remaining cases follow autosomal recessive inheritance, meaning both parents must carry a copy of the faulty gene. Mutations in one particular gene account for 20% of cases, while two other genes each contribute about 7%.
Symptoms of CGD
People with CGD typically experience a serious bacterial or fungal infection every few years, often starting in childhood. Pneumonia is the most common, and fungal pneumonia can develop after exposure to decaying organic material like mulch, dead leaves, or hay. Beyond the lungs, infections frequently affect the skin, liver, stomach and intestines, brain, and eyes.
Common symptoms during infections include fever, swollen and painful lymph nodes, a persistent runny nose, skin rashes or redness, mouth sores, difficulty swallowing, vomiting, and diarrhea. Between infections, many people with CGD feel relatively well, but the pattern of recurring, unusually severe infections is what typically prompts testing.
How CGD Is Treated
Treatment for CGD centers on preventing infections before they happen. Most people take daily preventive antibiotics and antifungal medications for life. When infections do break through, additional targeted antibiotics or antifungals are used. Some patients receive periodic injections of a protein called interferon-gamma, which helps boost the killing ability of their immune cells.
The only potentially curative option is a stem cell transplant, which replaces the patient’s defective immune system with a donor’s healthy one. Outcomes have improved significantly over the past two decades. A large European study of 712 CGD patients transplanted between 1993 and 2018 found overall survival of about 86% at three years. For children transplanted before age five, survival reached 100% in one single-center study of 55 patients. Adults fare somewhat less well, with three-year survival around 76%.
A prospective study of 56 patients who received a less intensive preparation regimen reported 93% overall survival with a median follow-up of 21 months, suggesting that newer, gentler transplant approaches may reduce risk. Still, transplant carries meaningful risks including graft-versus-host disease and infections during the recovery period, so it’s typically recommended for patients with severe or poorly controlled disease rather than offered to everyone with CGD.
Granulomatous Disease Beyond CGD
For the broader category of granulomatous diseases, treatment depends entirely on the underlying cause. Tuberculosis-related granulomas are treated with a months-long course of antibiotics. Sarcoidosis may not need treatment at all if symptoms are mild, since granulomas sometimes resolve on their own. When sarcoidosis does require treatment, immunosuppressive medications are used to calm the overactive immune response. Foreign body granulomas may need surgical removal of the offending material.
The diagnostic process usually involves imaging (chest X-rays or CT scans often reveal granulomas in the lungs) followed by a tissue biopsy to examine the granuloma under a microscope. The pattern of the granuloma, whether it has central dead tissue or not, what types of cells are present, and where in the body it’s located, all help determine which of the many granulomatous conditions is responsible. Blood tests and cultures for specific infections round out the workup.